Women with a history of biopsy-proven lobular carcinoma in situ (LCIS) appear to benefit from the addition of MRI to mammography for annual breast cancer screening. A retrospective study from Memorial Sloan-Kettering Cancer Institute presented Sunday at the 2010 RSNA meeting indicates the application of screening MRI for this at-risk population can double the cancer detection rate.